Aug 18, 2026Bora’s US growth strategy | Lonza launches rapid media prototyping service

Aug 15, 2026Halo’s new $45M fill-finish platform | Eurofins CDMO Alphora’s kilolab, HPAPI expansion

Aug 14, 2026FDA’s onshoring of generic drugs, APIs | Generic oligonucleotide API maker passes inspection

Aug 13, 2026Catalent launches enterprise AI tool | PerkinElmer’s Project Farma acquires SimoTech

Aug 12, 2026WuXi AppTec is victim of US-China relations | MilliporeSigma biosafety testing lab expansion

Aug 11, 2026BMS invests $2.3B in new Houston site | Novo Nordisk’s troubled Indiana facility

Aug 8, 2026Brewing drug ingredients like beer | Altruist’s PPQ campaign on 20,000L bioreactors

Aug 7, 2026Increasing demand for fill-finish manufacturing | AstraZeneca, CSPC form joint China venture

Aug 6, 2026Greg Slabodkin Lifecore to see jump in fill-finish demand | AsymBio to boost biologics CDMO capacity

Aug 5, 2026WuXi AppTec ups CapEx to boost global capacity | Piramal expands peptide API facility

Aug 4, 2026Samsung reports growth on full plant operations | CordenPharma closes AmbioPharm acquisition

Aug 1, 2026Bachem grows peptide, oligo capacity | Lab gets $8.5M to fast-track ebolavirus vaccine

Jul 31, 2026Lonza invests in Swiss ADC site | Octapharma to build $1.5B US manufacturing facility

Jul 30, 2026Gerresheimer inks $1.7B deal to sell packaging units | AGC Biologics secures multi-year contract

Jul 29, 2026Cell therapy manufacturing’s automated future | Harbour BioMed, Sinopharm team on R&D

Jul 28, 2026Thermo Fisher’s single-use strategy | Kyverna, ElevateBio sign manufacturing agreement

Jul 25, 2026Trump’s generic drug tariffs threaten US supply | New ophthalmic production site in France

Jul 24, 2026Siegfried overtakes Lonza in HPAPI race | BeOne invests $300M in NJ expansion

Jul 23, 2026Commerce Department funds Tech Hubs | Repligen boosts cell therapy business with $1.5B buy

Jul 22, 2026AstraZeneca’s award-winning cell therapy site | Cellares, Papillon team to automate manufacturing

Jul 21, 2026Samsung Biologics buys PolyPeptide for $1.8B | BMS, NVIDIA team on ‘AI factory’

Jul 18, 2026Senate bill targets foreign drugmaking in US | MilliporeSigma opens German testing facility

Jul 17, 2026J&J streamlines its pharma supply chain | Cytovance adds perfusion capabilities

Jul 16, 2026Bora Pharmaceuticals, Insilico Medicine form AI drug alliance | Formycon, OneSource team on biosimilars

Jul 15, 2026Biopharma demand poised to improve | Charles River provides GMP NGS services to Arovella

Latest Edition